✦ LIBER ✦

Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands

✍ Scribed by Nuijten, Mark; Lebmeier, Maximilian; Wittenberg, Wolfgang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5ICCN_037: Cost effectiveness of paliviz

✍ Soldatova, I.; Ignatyeva, V.; Avksentyeva, M.; Rebrova, O.; Gerasimova, K.; Asmo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Cost-Effectiveness Analysis of Palivizum

✍ Langenfeld, M.K.; Visser, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PIH1 COST-EFFECTIVENESS MODEL OF PALIVIZ

✍ MJ Nuijten; M Lebmeier; P Daalderop; W Wittenberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PIN79 SYSTEMATIC REVIEW OF THE COST-EFFE

✍ Paladio Duran, N; García-Altés, A; Pons Ràfols, JM; Tebé Cordomi, C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Palivizumab for respiratory syncytial vi

✍ Jennifer H. Lofland; Suzanne M. Touch; John P. O'Connor; Mary Lou Chatterton; El 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 890 KB

PIN35 COST-EFFECTIVENESS ANALYSIS OF PAL

✍ S Ikeda; M Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB